Don’t Mind the Index, Just Pick Your Stocks!

After the state election results were out the Nifty and Sensex reached historic highs (Nifty closed at 6363 after intraday high of 6414 and Sensex closed at 21326 after intraday high of 21483 ) bringing a sense of euphoria in market-watchers but for the seasoned investors, this was just another non-descript day in the market, quick to fade away into distant memory.

Earnings Season Snapshot - H1 FY 2013-14 - IT Sector

The IT industry has been and will continue to be an attractive option for investors due to the good returns it has given in the past and the potential to give better returns in the future. This sector will always remain the favourite with the investors because of the ability to give good RoI.

Earnings Season Snapshot - H1 FY 2013-14 - Pharma Sector

The pharmaceuticals industry in India has been the flavour of the market with its low beta nature and its standing as a wealth creator from the perspective of last 5yrs. It is one of the sectors which is affected minimally due to the domestic macro-economic condition as most of the business of this sector comes from outside India.

Earnings Season Snapshot - H1 FY 2013-14 - Banking Sector

The second quarter results of the banking sector were as per the expected guidelines. The blue chip companies in this sector were on the market radar from the start of this earnings season itself.

Play The Cyclical Markets - Pick Stocks For A Lifetime

If somebody were to sum-up the present macro-economic situation in India, they would probably sum it up as High Inflation Low Growth. As the IIP data for the past 12 months and the dismal GDP numbers reported so far and projected for the full year show, we are going through an economic low presently. But, for investors should search  good opportunities for investment in the present situation too.

Incredible Stocks - Lupin Limited

Lupin Limited is a well-known Indian pharmaceutical company which is the 4th largest by sales in India. It has established itself as an integrated global pharmaceutical company. 

Lupin’s products are well known in India and the world over too. In the therapeutic area Lupin’s anti-TB drug is No.1 globally.